AFP and neoplasm: AFP2-11 -HLA-A*24:02 specific TCR transfected T cells could specifically activate and kill AFP2-11 pulsed T2-A24 cells and AFP+ HLA-A*24:02+ tumor cell lines, demonstrating that AFP2-11 epitope can be naturally presented on the surface of AFP+ tumor cell lines [115].